International Conference on Immunometabolism and Diabetes Research (ICIMDR - 26)

This session will explore the intricate immunometabolic pathways that contribute to the pathogenesis of diabetes. Emphasis will be placed on the role of immune cells in regulating metabolic processes and their implications for diabetes management.

This track will focus on the relationship between chronic inflammation and various metabolic disorders, including obesity and type 2 diabetes. Presentations will highlight novel therapeutic strategies targeting inflammatory pathways to improve metabolic health.

This session will examine how immune cells influence glucose metabolism and insulin sensitivity. Researchers will present findings on the mechanisms by which immune regulation affects metabolic homeostasis in diabetes.

This track will showcase cutting-edge translational research aimed at bridging the gap between basic immunometabolism and clinical applications in diabetes. Discussions will include innovative strategies for translating laboratory findings into therapeutic interventions.

This session will delve into the mechanisms underlying metabolic inflammation and its consequences for diabetes progression. Researchers will discuss the role of cytokines and immune mediators in driving metabolic dysregulation.

This track will explore the metabolic profiles of various immune cell types and their implications for health and disease. Presentations will focus on how alterations in immune cell metabolism can influence the development of metabolic disorders.

This session will investigate the interplay between gut microbiota, immune responses, and metabolic health. Researchers will present data on how microbiota composition affects immune regulation and metabolic outcomes in diabetes.

This track will highlight emerging biomarkers that can aid in the understanding and management of immunometabolic disorders. Presentations will focus on the potential of these biomarkers for predicting disease progression and treatment responses.

This session will discuss potential therapeutic targets within the immunometabolic framework for diabetes treatment. Researchers will present innovative approaches to modulate immune responses to improve metabolic health.

This track will explore the role of adipose tissue as an active endocrine organ in regulating immune and metabolic functions. Presentations will focus on the implications of adipose tissue inflammation for diabetes and metabolic syndrome.

This session will address the clinical implications of recent findings in immunometabolism for diabetes care. Discussions will focus on how understanding immune-metabolic interactions can inform patient management and therapeutic strategies.